Synapse

← Cardiovascular Endocrinology & Metabolism

Papers in Cardiovascular Endocrinology & Metabolism

Page 2 · newest first

  1. Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysisCardiovascular Endocrinology & Metabolism · 2023
  2. Relationship between the triglyceride-glucose index and the SYNTAX score 2 in patients with non-ST elevation myocardial infarctionCardiovascular Endocrinology & Metabolism · 2023
  3. Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohortCardiovascular Endocrinology & Metabolism · 2023
  4. Real-world demographic patterns of users of a digital primary prevention service for diabetesCardiovascular Endocrinology & Metabolism · 2022
  5. Does food responsiveness change in people with first-episode psychosis over a period of 3 months after commencing antipsychotics? Preliminary resultsCardiovascular Endocrinology & Metabolism · 2022
  6. Cardiometabolic syndrome in HIV-positive and HIV-negative patients at Zewditu Memorial Hospital, Addis Ababa, Ethiopia: a comparative cohort studyCardiovascular Endocrinology & Metabolism · 2022
  7. Cardiac autonomic neuropathy linked to left ventricular dysfunction in type 1 diabetic patientsCardiovascular Endocrinology & Metabolism · 2022
  8. National level prescribing of psychotropic medication in primary care during the COVID-19 pandemic in England: potential implications for cardiometabolic healthCardiovascular Endocrinology & Metabolism · 2022
  9. Preexisting atrial fibrillation and myocardial infarction: only 10% of infarcts directly linked to atrial fibrillationCardiovascular Endocrinology & Metabolism · 2022
  10. A retrospective real-world observational pilot analysis of Waya: a self-monitoring fitness app in GermanyCardiovascular Endocrinology & Metabolism · 2022
  11. Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?Cardiovascular Endocrinology & Metabolism · 2022
  12. Naltrexone alters cardiovascular function following acute forced swimming in miceCardiovascular Endocrinology & Metabolism · 2022
  13. Reducing fatigue-related symptoms in Long COVID-19: a preliminary report of a lymphatic drainage interventionCardiovascular Endocrinology & Metabolism · 2022
  14. A survey of physician experience and treatment satisfaction prescribing once-weekly semaglutide injections for patients with type 2 diabetes in CanadaCardiovascular Endocrinology & Metabolism · 2022
  15. Hormonal and metabolic profiles of obese and nonobese type 2 diabetes patients: implications of plasma insulin, ghrelin, and vitamin D levelsCardiovascular Endocrinology & Metabolism · 2022
  16. Genetic association of LPL rs326 with BMI among the Kuwaiti populationCardiovascular Endocrinology & Metabolism · 2021
  17. The microvascular hypothesis underlying neurologic manifestations of long COVID-19 and possible therapeutic strategiesCardiovascular Endocrinology & Metabolism · 2021
  18. Correlation between the ankle–brachial index and microalbuminuria with certain risk factors in type 2 diabetes patientsCardiovascular Endocrinology & Metabolism · 2021
  19. Recalibration of thinking about adrenocortical function assessment: how the ‘random’ cortisol relates to the short synacthen test resultsCardiovascular Endocrinology & Metabolism · 2021
  20. Atypical hemolytic uremic syndrome: when pregnancy leads to lifelong dialysis: a case report and literature reviewCardiovascular Endocrinology & Metabolism · 2021
  21. Successful use of the sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with renal transplant and diabetes: a case series and literature reviewCardiovascular Endocrinology & Metabolism · 2021
  22. The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysisCardiovascular Endocrinology & Metabolism · 2021
  23. Investigation of polycystic ovarian syndrome: variation in practice and impact on the speed of diagnosisCardiovascular Endocrinology & Metabolism · 2021
  24. Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United StatesCardiovascular Endocrinology & Metabolism · 2021
  25. Salivary markers and coronavirus disease 2019: insights from cross-talk between the oral microbiome and pulmonary and systemic low-grade inflammation and implications for vascular complicationsCardiovascular Endocrinology & Metabolism · 2021
  26. Speckle tracking echocardiographic assessment of left ventricular longitudinal strain in female patients with subclinical hyperthyroidismCardiovascular Endocrinology & Metabolism · 2020
  27. The acute vs. chronic effect of exercise on insulin sensitivity: nothing lasts foreverCardiovascular Endocrinology & Metabolism · 2020
  28. Novel biomarkers for subtle myocardial involvement in type I diabetes mellitusCardiovascular Endocrinology & Metabolism · 2020
  29. Testosterone, HIV, and cardiovascular disease riskCardiovascular Endocrinology & Metabolism · 2020
  30. Evaluation of diastolic function in newly diagnosed hyperthyroid patients with preserved left ventricular systolic functionCardiovascular Endocrinology & Metabolism · 2020
  31. The relationship between plasma vitamin D level and heart valves calcification in acute coronary syndrome and non acute coronary syndrome patientsCardiovascular Endocrinology & Metabolism · 2020
  32. COVID-19 pandemic: a glimpse into newly diagnosed hypertensive patientsCardiovascular Endocrinology & Metabolism · 2020
  33. Hyperthyroidism in severe mitral regurgitation post mechanical mitral valve replacement: the effect on warfarin anticoagulationCardiovascular Endocrinology & Metabolism · 2020
  34. Exercise, cancer and cardiovascular disease: what should clinicians advise?Cardiovascular Endocrinology & Metabolism · 2020
  35. Analogous telomeres shortening and different metabolic profile: hypertension versus hypertension/type 2 diabetes mellitus comorbidityCardiovascular Endocrinology & Metabolism · 2020
  36. The association between left ventricular mass index and serum sirtuin 3 level in patients with hypertensionCardiovascular Endocrinology & Metabolism · 2020
  37. Comprehensive evaluation of cardiovascular efficacy and safety outcomes of SGLT2 inhibitors in high risk patients of cardiovascular disease: systematic review and meta-analysisCardiovascular Endocrinology & Metabolism · 2020
  38. Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycaemia in men with type 2 diabetes mellitus: a prospective cohort studyCardiovascular Endocrinology & Metabolism · 2020
  39. Visceral fat reduction and increase of intracellular fluid in weight loss participants on antihypertension medicationCardiovascular Endocrinology & Metabolism · 2020
  40. Coronary microvascular disease: current concepts of pathophysiology, diagnosis and managementCardiovascular Endocrinology & Metabolism · 2020
  41. Cardiometabolic medicine – the US perspective on a new subspecialtyCardiovascular Endocrinology & Metabolism · 2020
  42. Rapid progression of aortic stenosis after initiation of teriparatide treatment: a case reportCardiovascular Endocrinology & Metabolism · 2020
  43. Type 2 diabetes prevalence in Pakistan: what is driving this? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of PakistanCardiovascular Endocrinology & Metabolism · 2020
  44. Peroxisome proliferator-activated receptor agonists and reversal of vascular degeneration through DNA repair, a step toward drug-induced regenerative medicineCardiovascular Endocrinology & Metabolism · 2020
  45. The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UKCardiovascular Endocrinology & Metabolism · 2020
  46. Obese communities among the best predictors of COVID-19-related deathsCardiovascular Endocrinology & Metabolism · 2020
  47. Cardiovascular and cardiometabolic prevention: high-level priority in the era of COVID-19Cardiovascular Endocrinology & Metabolism · 2020
  48. Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics dataCardiovascular Endocrinology & Metabolism · 2020
  49. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19Cardiovascular Endocrinology & Metabolism · 2020
  50. Revisiting the pathogenic role of insulin resistance in Duchenne muscular dystrophy cardiomyopathy subphenotypesCardiovascular Endocrinology & Metabolism · 2020